Cancel
Nanograb
See Linkedin
Nanograb Employees
4 people indexed:
-
jj4e5@kj3w5q4t.8ju Sign up to see email
-
689820.tq1yw0@f0qw9040.z11 Sign up to see email
-
t0vyuw@u57d5wqq.quz Sign up to see email
-
qzvhddj@i2vy8p3w.vzx Sign up to see email
Nanograb Company Information
Nanograb is a healthcare company with locations in San Francisco, CA, USA, and London, England, United Kingdom. The company operates in the drug discovery and delivery sub-industry and uses artificial intelligence to generate optimal combinations of binders for treating various diseases. Their product enables drugs to be precisely targeted to specific areas of the body, utilizing multivalent nanoparticles with next-generation targeting capabilities. Nanograb launched in 2023 and participated in Y Combinator’s S23 batch. The team consists of three scientists who have extensive experience in the scientific world and have worked together for years. They bring a fresh perspective to translating their scientific knowledge into practical products. Nanograb serves regions including the United States, United Kingdom, America/Canada, and Europe.
Report inaccurate information
Report inaccurate information
